XXII World Congress of Asthma - Scientific Programme Committee Message

"Translating science into clinical practice: how to improve asthma management in 2014"

.
Significant achievements have been accomplished in the last few years in better understanding what asthma is, how it should be assessed in regard to control and severity and what its optimal therapy is. Unfortunately these improvements in our understanding of the disease have not always translated into better asthma management.
.
The 2014 World Congress on Asthma in Mexico City will review the key findings from recent research on both adult and paediatric asthma and how knowledge translation methods have evolved to better integrate research findings into care.
.
The origins and determinants of asthma, triggers and inducers, the new insight gained on the role of allergy, environmental and biodiversity changes, workplace hazards, respiratory infections and various aspects of assessment of the disease are among the topics that will be covered by world experts. The role of phenotyping/endotyping asthma, particularly when severe, and new therapeutic current and future advances will be covered.
.
A significant part of the meeting will be devoted to practical workshops on asthma testing and treatment delivery, as well as the integration of practice tools into day-to-day care. Sessions will discuss how to optimize the multidisciplinary approach to asthma management.
.
We and the members of the scientific and pediatric advisory board believe the impressive programme of WCA-2014 will be of interest to all those involved in research and care of asthma.

 

Lawrence DuBuske

..

Louis-Philippe Boulet

..

G. Walter Canonica

..

Carlos E. Baena-Cagnani

Lawrence DuBuske   Louis-Philippe Boulet   G. Walter Canonica   Carlos E. Baena-Cagnani

.
on behalf of the Scientific Programme Committee –WCA 2014 Mexico City INTERASMA

(You must be logged in to add and reply comments)

Interasma on Twitter

Interasma RT @Aller_MD: Top story: Is it a food allergy? https://t.co/ESaWtExlry, see more https://t.co/jgCeENQuZt
4hreplyretweetfavorite
Interasma RT @Aller_MD: #Dupilumab (Dupixent) is known to help control atopic dermatitis by diminishing interleukin (IL)-13, but that same mechanism…
4hreplyretweetfavorite
Interasma RT @Aller_MD: “Nasal delivery of leptin hormone may help ease breathing problems during sleep” https://t.co/kPhCp7YbFw https://t.co/mNuyNkD
4hreplyretweetfavorite
Interasma RT @Aller_MD: The 'greying' of T cells: Scientists pinpoint metabolic pathway behind age-related immunity loss https://t.co/V2QIjHJPn1
4hreplyretweetfavorite
Interasma RT @Aller_MD: The latest Allergy, Asthma & Immunology! https://t.co/Thi7i4hPcI Thanks to @GoAllergy @CochraneAirways #eehealthchoices #immu
4hreplyretweetfavorite

Editor: Juan C. Ivancevich, MD

Copyright © Interasma 2003-2017  •  Terms of Use  •  Privacy Policy  •  Contact Us  •  Sitemap

Powered by FREI SA

InterAsma